JAZZ: 爵士制药

JAZZ新闻

• 16:30 Morgan Stanley Maintains Overweight on Jazz Pharmaceuticals, Lowers Price Target to $314
• 14:00 Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
• 20:33 Stocks Finish Mostly Higher on Earnings Optimism
• 15:25 Stocks Rebound on Strong Earnings and Lower Bond Yields
• 14:09 Stocks Pressured by Tech Stock Weakness and Higher Crude Oil Prices
• 12:17 Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?
• 11:12 HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
• 20:34 Stocks Settle Mixed as Broader Market Recovers from Chip Stock Rout
• 15:27 Stock Indexes Rebound as Investors Rotate Out of Chip Stocks
• 12:43 Jazz Pharmaceuticals: Ziihera And Portfolio Diversification Are Changing Earnings Story
• 15:18 Stocks and Bonds Fall on a Strong CPI Report
• 20:44 Stocks Finish Lower Ahead of Wednesday’s CPI Report
• 11:39 Jim Cramer Gives Green Light To This Health Care Stock
• 14:49 RBC资本维持对Jazz Pharmaceuticals的“跑赢大盘”评级，将目标价下调至296美元
• 14:49 RBC Capital Maintains Outperform on Jazz Pharmaceuticals, Lowers Price Target to $296
• 16:50 Truist Securities Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $286
• 12:40 Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
• 18:30 This Cancer Drug Is Already Working. Now Its Nvidia-Backed Maker Is Going Public: Here’s What You Need to Know About Its IPO
• 12:48 Alkermes: Idiopathic Hypersomnia Could Expand LUMRYZ Into A Larger Growth, Margin Driver
• 13:05 Goldman Sachs Reinstates Buy on Jazz Pharmaceuticals, Announces $337 Price Target
• 13:05 高盛恢复对爵士制药的买入评级，宣布337美元的目标股价
• 14:17 ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know
• 22:22 Harmony Gold Mining Joins IBD Sector Leaders; 18 Other Stocks Graduate To IBD Watchlists
• 22:36 Lumentum, WisdomTree, Incyte Among 15 Stocks Popping Up On IBD's Roving Watchlists